Survival dimensionality reduction (SDR): development and clinical application of an innovative approach to detect epistasis in presence of right-censored data
<p>Abstract</p> <p>Background</p> <p>Epistasis is recognized as a fundamental part of the genetic architecture of individuals. Several computational approaches have been developed to model gene-gene interactions in case-control studies, however, none of them is suitable...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-08-01
|
Series: | BMC Bioinformatics |
Online Access: | http://www.biomedcentral.com/1471-2105/11/416 |
id |
doaj-1223753b355d40b09e0252f82c3914fe |
---|---|
record_format |
Article |
spelling |
doaj-1223753b355d40b09e0252f82c3914fe2020-11-24T21:20:19ZengBMCBMC Bioinformatics1471-21052010-08-0111141610.1186/1471-2105-11-416Survival dimensionality reduction (SDR): development and clinical application of an innovative approach to detect epistasis in presence of right-censored dataBeretta LorenzoSantaniello Alessandrovan Riel Piet LCMCoenen Marieke JHScorza Raffaella<p>Abstract</p> <p>Background</p> <p>Epistasis is recognized as a fundamental part of the genetic architecture of individuals. Several computational approaches have been developed to model gene-gene interactions in case-control studies, however, none of them is suitable for time-dependent analysis. Herein we introduce the Survival Dimensionality Reduction (SDR) algorithm, a non-parametric method specifically designed to detect epistasis in lifetime datasets.</p> <p>Results</p> <p>The algorithm requires neither specification about the underlying survival distribution nor about the underlying interaction model and proved satisfactorily powerful to detect a set of causative genes in synthetic epistatic lifetime datasets with a limited number of samples and high degree of right-censorship (up to 70%). The SDR method was then applied to a series of 386 Dutch patients with active rheumatoid arthritis that were treated with anti-TNF biological agents. Among a set of 39 candidate genes, none of which showed a detectable marginal effect on anti-TNF responses, the SDR algorithm did find that the rs1801274 SNP in the FcγRIIa gene and the rs10954213 SNP in the IRF5 gene non-linearly interact to predict clinical remission after anti-TNF biologicals.</p> <p>Conclusions</p> <p>Simulation studies and application in a real-world setting support the capability of the SDR algorithm to model epistatic interactions in candidate-genes studies in presence of right-censored data.</p> <p>Availability: <url>http://sourceforge.net/projects/sdrproject/</url></p> http://www.biomedcentral.com/1471-2105/11/416 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Beretta Lorenzo Santaniello Alessandro van Riel Piet LCM Coenen Marieke JH Scorza Raffaella |
spellingShingle |
Beretta Lorenzo Santaniello Alessandro van Riel Piet LCM Coenen Marieke JH Scorza Raffaella Survival dimensionality reduction (SDR): development and clinical application of an innovative approach to detect epistasis in presence of right-censored data BMC Bioinformatics |
author_facet |
Beretta Lorenzo Santaniello Alessandro van Riel Piet LCM Coenen Marieke JH Scorza Raffaella |
author_sort |
Beretta Lorenzo |
title |
Survival dimensionality reduction (SDR): development and clinical application of an innovative approach to detect epistasis in presence of right-censored data |
title_short |
Survival dimensionality reduction (SDR): development and clinical application of an innovative approach to detect epistasis in presence of right-censored data |
title_full |
Survival dimensionality reduction (SDR): development and clinical application of an innovative approach to detect epistasis in presence of right-censored data |
title_fullStr |
Survival dimensionality reduction (SDR): development and clinical application of an innovative approach to detect epistasis in presence of right-censored data |
title_full_unstemmed |
Survival dimensionality reduction (SDR): development and clinical application of an innovative approach to detect epistasis in presence of right-censored data |
title_sort |
survival dimensionality reduction (sdr): development and clinical application of an innovative approach to detect epistasis in presence of right-censored data |
publisher |
BMC |
series |
BMC Bioinformatics |
issn |
1471-2105 |
publishDate |
2010-08-01 |
description |
<p>Abstract</p> <p>Background</p> <p>Epistasis is recognized as a fundamental part of the genetic architecture of individuals. Several computational approaches have been developed to model gene-gene interactions in case-control studies, however, none of them is suitable for time-dependent analysis. Herein we introduce the Survival Dimensionality Reduction (SDR) algorithm, a non-parametric method specifically designed to detect epistasis in lifetime datasets.</p> <p>Results</p> <p>The algorithm requires neither specification about the underlying survival distribution nor about the underlying interaction model and proved satisfactorily powerful to detect a set of causative genes in synthetic epistatic lifetime datasets with a limited number of samples and high degree of right-censorship (up to 70%). The SDR method was then applied to a series of 386 Dutch patients with active rheumatoid arthritis that were treated with anti-TNF biological agents. Among a set of 39 candidate genes, none of which showed a detectable marginal effect on anti-TNF responses, the SDR algorithm did find that the rs1801274 SNP in the FcγRIIa gene and the rs10954213 SNP in the IRF5 gene non-linearly interact to predict clinical remission after anti-TNF biologicals.</p> <p>Conclusions</p> <p>Simulation studies and application in a real-world setting support the capability of the SDR algorithm to model epistatic interactions in candidate-genes studies in presence of right-censored data.</p> <p>Availability: <url>http://sourceforge.net/projects/sdrproject/</url></p> |
url |
http://www.biomedcentral.com/1471-2105/11/416 |
work_keys_str_mv |
AT berettalorenzo survivaldimensionalityreductionsdrdevelopmentandclinicalapplicationofaninnovativeapproachtodetectepistasisinpresenceofrightcensoreddata AT santanielloalessandro survivaldimensionalityreductionsdrdevelopmentandclinicalapplicationofaninnovativeapproachtodetectepistasisinpresenceofrightcensoreddata AT vanrielpietlcm survivaldimensionalityreductionsdrdevelopmentandclinicalapplicationofaninnovativeapproachtodetectepistasisinpresenceofrightcensoreddata AT coenenmariekejh survivaldimensionalityreductionsdrdevelopmentandclinicalapplicationofaninnovativeapproachtodetectepistasisinpresenceofrightcensoreddata AT scorzaraffaella survivaldimensionalityreductionsdrdevelopmentandclinicalapplicationofaninnovativeapproachtodetectepistasisinpresenceofrightcensoreddata |
_version_ |
1726002791552385024 |